Delivery Order SPE2DB22D2007-SPE2DB24FJ0JG
Award Date 3/8/24
Potential Completion Date 3/11/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,320.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The award is a delivery order with a firm fixed price and has an ultimate completion date of May 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award, valued at $5,843.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award, valued at $2,528.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a completion date of February 15, 2024. This award is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant...
- This federal contract award, valued at $1,163.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a prescription medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 12, 2025. This award is not associated with a set-aside designation, indicating open...
- This federal contract award, valued at $1,936.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued...
- This federal contract award, valued at $2,121.12, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
- The federal contract award, valued at $11,823.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% patches, a pharmaceutical product used for pain management. This is a Firm Fixed Price Delivery Order contract with a completion date of January 29, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
- This federal contract award, valued at $1,387.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary...
- This federal contract award, valued at $1,644.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to support military healthcare programs. The contract has a completion date of May 10, 2024 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
- This federal contract award, valued at $10,852.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Lidocaine 5% Patch, a pharmaceutical product used for pain management. The contract is a firm fixed-price Delivery Order that runs through February 1, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...